A new two dose, twice weekly combined 17B oestradiol and norethisterone patch is now available to complement existing options for HRT prescribing.
Licensed for postmenopausal women with estrogen deficiency symptoms, the new patch offers either 30 mcg 17B oestradiol with 95 mcg norethisterone or 40 mcg 17B oestradiol with 130 mcg norethisterone.
Professor Janice Rymer, BMS Chair, said:
‘With individualised prescribing at the centre of best practice menopause care, we welcome the availability of new products to offer healthcare professionals a greater range of choices for personalising prescribing for their patients.’